Isofol Medical AB (publ) earnings
Annual earnings per share (SEK per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2022 | 2022-12-31 | SEK -0.99 | SEK -0.99 | 2026-06-19T06:16:51Z |
| 2021 | 2021-12-31 | SEK -1.59 | SEK -1.59 | 2026-06-19T06:16:51Z |
Revenue & profit (SEK)
| Concept | 2022 | 2021 |
|---|---|---|
| Revenue | SEK 12.8M | SEK 22.4M |
| Profit for the year | -SEK 159.8M | -SEK 200.3M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in Isofol Medical AB (publ)'s ESEF annual reports (source:
filings.xbrl.org).
Figures are in SEK, as reported. Not investment advice.